title: Sister chromatid exchanges and cell proliferative abilities in cultured peripheral blood lymphocytes of patients with rheumatoid and reactive arthritis.
abstract: OBJECTIVE
  Analysis of cytogenetic alterations in peripheral blood lymphocytes (PBL) of patients with acute and chronic reactive arthritis (AcReA and ChrReA) and rheumatoid arthritis (RA).
  
  
  METHODS
  The frequencies of sister chromatid exchanges (SCE) and cell proliferative abilities were analysed in PBL from 69 patients with arthritis and 30 healthy controls. The analyses were done on metaphase chromosomes from PBL grown in cell culture for 72 hours. Cytogenetic parameters were compared among study groups and correlations with different clinical, immune and demographic characteristics were analysed.
  
  
  RESULTS
  No significant increases in the frequencies of SCE were detected in PBL from patients with AcReA, ChrReA and RA as compared to controls. However, marked impairment of cell proliferative abilities was detected in cultured lymphocytes from patients with arthritis as compared to healthy controls. Significant associations between measures of disease activity and proliferative abilities of PBL were established. Parameters of lymphocyte proliferation were also influenced by concentration of anti-inflammatory cytokine interleukin-10 in the blood of patients.
  
  
  CONCLUSIONS
  No increased risk of genetic alterations as measured by the rate of SCE was found in patients with RA and ReA. It is most likely that impaired proliferative abilities of peripheral blood lymphocytes are related to disease activity and could reflect systemic changes in cytokines production and intracellular signal transduction.
authors.affiliation: Laboratory of Ecological Genetics, Vilnius University, Lithuania.
authors.forename: S
authors.initials: S
authors.lastname: Jarmalaite
authors.forename: J
authors.initials: J
authors.lastname: Mierauskiene
authors.forename: K
authors.initials: K
authors.lastname: Beitas
authors.forename: J
authors.initials: J
authors.lastname: Ranceva
authors.forename: J R
authors.initials: JR
authors.lastname: Lazutka
authors.forename: I
authors.initials: I
authors.lastname: Butrimiene
mesh_terms: D000208:Acute Disease; D000328:Adult; D016918:Arthritis, Reactive / Q000097:blood*; D001172:Arthritis, Rheumatoid / Q000097:blood*; D016022:Case-Control Studies; D049109:Cell Proliferation; D002478:Cells, Cultured; D002869:Chromosome Aberrations; D002908:Chronic Disease; D003710:Demography; D005260:Female; D006801:Humans; D016753:Interleukin-10 / Q000378:metabolism; D008213:Lymphocyte Activation / Q000235:genetics*; D008214:Lymphocytes / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D000091402:Prohibitins; D012854:Sister Chromatid Exchange / Q000235:genetics*
chemical_list: C000717331:PHB2 protein, human; D000091402:Prohibitins; D016753:Interleukin-10